-+ 0.00%
-+ 0.00%
-+ 0.00%

WHITEHAWK THERAPEUTICS, INC. : STIFEL INITIATES COVERAGE WITH BUY RATING; PRICE TARGET $9

Reuters·10/01/2026 10:46:10

Please log in to view news